Kang Heeseog, Aryal Ac Smriti, Barnes Aileen M, Martin Aline, David Valentin, Crawford Susan E, Marini Joan C
Section on Heritable Disorders of Bone and Extracellular Matrix, NICHD, NIH, Bethesda, MD, USA.
Division of Nephrology and Hypertension, Department of Medicine, and Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
J Bone Miner Res. 2022 May;37(5):925-937. doi: 10.1002/jbmr.4540. Epub 2022 Apr 13.
Osteogenesis imperfecta (OI) is a heterogeneous genetic disorder of bone and connective tissue, also known as brittle bone disease. Null mutations in SERPINF1, which encodes pigment epithelium-derived factor (PEDF), cause severe type VI OI, characterized by accumulation of unmineralized osteoid and a fish-scale pattern of bone lamellae. Although the potent anti-angiogenic activity of PEDF has been extensively studied, the disease mechanism of type VI OI is not well understood. Using Serpinf1 mice and primary osteoblasts, we demonstrate that loss of PEDF delays osteoblast maturation as well as extracellular matrix (ECM) mineralization. Barium sulfate perfusion reveals significantly increased vessel density in the tibial periosteum of Serpinf1 mouse compared with wild-type littermates. The increased bone vascularization in Serpinf1 mice correlated with increased number of CD31(+)/Endomucin(+) endothelial cells, which are involved in the coupling angiogenesis and osteogenesis. Global transcriptome analysis by RNA-Seq of Serpinf1 mouse osteoblasts reveals osteogenesis and angiogenesis as the biological processes most impacted by loss of PEDF. Intriguingly, TGF-β signaling is activated in type VI OI cells, and Serpinf1 osteoblasts are more sensitive to TGF-β stimulation than wild-type osteoblasts. TGF-β stimulation and PEDF deficiency showed additive effects on transcription suppression of osteogenic markers and stimulation of pro-angiogenic factors. Furthermore, PEDF attenuated TGF-β-induced expression of pro-angiogenic factors. These data suggest that functional antagonism between PEDF and TGF-β pathways controls osteogenesis and bone vascularization and is implicated in type VI OI pathogenesis. This antagonism may be exploited in developing therapeutics for type VI OI utilizing PEDF and TGF-β antibody. © 2022 American Society for Bone and Mineral Research (ASBMR). This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
成骨不全症(OI)是一种骨骼和结缔组织的异质性遗传疾病,也被称为脆骨病。编码色素上皮衍生因子(PEDF)的SERPINF1基因发生无效突变会导致严重的VI型OI,其特征是未矿化类骨质的积累和骨板的鱼鳞状模式。尽管PEDF强大的抗血管生成活性已得到广泛研究,但VI型OI的发病机制尚不清楚。我们使用Serpinf1小鼠和原代成骨细胞证明,PEDF的缺失会延迟成骨细胞成熟以及细胞外基质(ECM)矿化。硫酸钡灌注显示,与野生型同窝小鼠相比,Serpinf1小鼠胫骨骨膜中的血管密度显著增加。Serpinf1小鼠中骨血管生成增加与参与血管生成和成骨偶联的CD31(+)/Endomucin(+)内皮细胞数量增加相关。通过RNA-Seq对Serpinf1小鼠成骨细胞进行的全转录组分析显示,成骨和血管生成是受PEDF缺失影响最大的生物学过程。有趣的是,TGF-β信号通路在VI型OI细胞中被激活,并且Serpinf1成骨细胞比野生型成骨细胞对TGF-β刺激更敏感。TGF-β刺激和PEDF缺乏对成骨标志物的转录抑制和促血管生成因子的刺激具有累加效应。此外,PEDF减弱了TGF-β诱导的促血管生成因子的表达。这些数据表明,PEDF和TGF-β信号通路之间的功能拮抗作用控制着成骨和骨血管生成,并与VI型OI的发病机制有关。这种拮抗作用可能被用于开发利用PEDF和TGF-β抗体治疗VI型OI的疗法。© 2022美国骨与矿物质研究学会(ASBMR)。本文由美国政府雇员撰写,在美国其作品属于公共领域。